Hitachi, Ltd. has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system. In the comprehensive public tender process, Hitachi has been ...
TAE Life Sciences (TLS), a leading developer of Boron Neutron Capture Therapy (BNCT) systems and drugs, and the Italian National Center for Oncological Hadrontherapy (CNAO), a premier hadrontherapy ...
A groundbreaking deal has been agreed with CNAO (National Center for Oncological Hadrontherapy) in Pavia, Italy. Marie® an upright patient positioning system combined with a vertical CT scanner, which ...
TAE Life Sciences (TLS), a biologically-targeted radiation therapy company developing a breakthrough, accelerator-based boron neutron capture therapy (BNCT) system, today announced that it has entered ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
TOKYO, Dec 6, 2019 - (JCN Newswire) - - Hitachi, Ltd. (TSE:6501) has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results